EDGAR Filing Documents for 0001209191-09-058150

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-09-058150

Filing Date

2009-12-21

Accepted

2009-12-21 16:31:08

Documents

Period of Report

2009-12-17

Document Format Files

Seq	Description	Document	Type	Size
1	MAIN DOCUMENT DESCRIPTION	c93917_4x0.html	4
1	MAIN DOCUMENT DESCRIPTION	c93917_4x0.xml	4	6787
	Complete submission text file	0001209191-09-058150.txt		10544

Mailing Address TWO NORTH RIVERSIDE PLAZA CHICAGO IL 60606

Business Address TWO NORTH RIVERSIDE PLAZA CHICAGO IL 60606 3124541800

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50414 | Film No.: 091252673

Mailing Address 20425 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876

Business Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20878 (301) 944-6600

MiddleBrook Pharmaceuticals, Inc. (Issuer) CIK: 0001161924 (see all company filings)

IRS No.: 522208264 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO NORTH RIVERSIDE PLAZA SUITE 600 CHICAGO IL 60606

Business Address TWO NORTH RIVERSIDE PLAZA SUITE 600 CHICAGO IL 60606 3124663281

State of Incorp.: IL | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50414 | Film No.: 091252672

Mailing Address TWO NORTH RIVERSIDE PLAZA SUITE 600 CHICAGO IL 60606

Business Address TWO NORTH RIVERSIDE PLAZA SUITE 600 CHICAGO IL 60606 312-466-3281

EGI-Fund (08-10) Investors, L.L.C. (Reporting) CIK: 0001399359 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50414 | Film No.: 091252674

Mailing Address TWO NORTH RIVERSIDE PLAZA SUITE 600 CHICAGO IL 60606

Business Address TWO NORTH RIVERSIDE PLAZA SUITE 600 CHICAGO IL 60606 312-466-3301

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50414 | Film No.: 091252675